Transcatheter mitral valve repair (TMVR) devices are used for minimally invasive treatment of mitral regurgitation (MR). Mitral regurgitation (MR), also known as mitral insufficiency, is caused by insufficient systolic coaptation of the mitral valve leaflets along with a change in the pressure gradient between the atrium and left ventricle. There are two types of MR: degenerative (primary), and functional (secondary). In Europe, transcatheter mitral valve repair (TMVR) is indicated for both primary and secondary MR. Transcatheter Mitral Valve Repair (TMVR) is FDA approved for both primary and secondary MR. Mitral valve repair treatment is preferred over mitral valve replacement in eligible patients because it is linked with lower short-term and long-term mortality and morbidity rates.
Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are :
Currently marketed Transcatheter Mitral Valve Repair (TMVR) market and evolving competitive landscape :
- Insightful review of the key industry trends.
- Annualized total Transcatheter Mitral Valve Repair (TMVR) market revenue by segment and market outlooks from 2015-2033.
- Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights :
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition the analyst analysts provide unique country specific insights on the market.
- SWOT analysis for Transcatheter Mitral Valve Repair (TMVR) market.
- Competitive dynamics insights and trends provided Transcatheter Mitral Valve Repair (TMVR) market.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Companies covered: Abbott Laboratories, Edwards Lifesciences Corp, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for :- CMO executives who must have deep understanding of the Transcatheter Mitral Valve Repair (TMVR) Devices marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to :
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
- Develop business strategies by understanding the trends shaping and driving Transcatheter Mitral Valve Repair (TMVR) market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Transcatheter Mitral Valve Repair (TMVR) market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Transcatheter Mitral Valve Repair (TMVR) market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Edwards Lifesciences Corp Others